Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Sourcing of human peripheral blood-derived myeloid angiogenic cells under xeno-free conditions for the treatment of critical limb ischemia

Fig. 1

Adherent cells sourced from PBMCs under XF/SF conditions exhibited BDAC characteristics. A Phase contrast images of adherent cells sourced from PBMCs under XF/SF conditions after 7 days of culture. B Number of adherent cells per initial volume of peripheral blood after 7 days of culture. C Flow cytometry analysis for hematopoietic marker CD45 and CD11b expression by adherent cells sourced from PBMC cultured in various media (n = 3). D Immunocytochemistry for pericyte markers NG2 and PDGFR-β expressed by adherent cells sourced from PBMC cultured in various culture media

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512